Evaluation of IL-4, IL-17, and IFN-γ Levels in PatientsWith Breast Cancer

Mina Rohani Borj ¹, Ali Reza Andalib ², Abbas Mohammadi ³, Seyed Mojtba Hoseiniharouni ⁴, Hossein Pourghadamyari ⁵, Hakim Azizi ⁶, Taghi Golmahammadi ⁵, Kamran Moghaddas Ghahfarokhy ⁷ *

Cited by CrossRef: 7

1- Lee C. Epithelial-mesenchymal transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids. Biochemical Pharmacology. 2018;158:261 [Crossref]

2- Ali E, Masri M, Siddig E, Ahmed A, Muneer M, Mohamed N, Edris A. Immunohistochemical expression of interleukin-17 and hormonal receptors in benign and malignant breast lesions. BMC Res Notes. 2020;13(1) [Crossref]

3- Jørgensen N, Sayed A, Jeppesen H, Persson G, Weisdorf I, Funck T, Hviid T. Characterization of HLA-G Regulation and HLA Expression in Breast Cancer and Malignant Melanoma Cell Lines upon IFN-γ Stimulation and Inhibition of DNA Methylation. IJMS. 2020;21(12):4307 [Crossref]

4- Jain M, Mishra A, Yadav V, Shyam H, Kumar S, Mishra S, Ramakant P. Long-Term Yogic Intervention Improves Symptomatic Scale and Quality of Life by Reducing Inflammatory Cytokines and Oxidative Stress in Breast Cancer Patients Undergoing Chemotherapy and/or Radiotherapy: A Randomized Control Study. 2023; [Crossref]

5- Bel’skaya L, Loginova A, Sarf E. Pro-Inflammatory and Anti-Inflammatory Salivary Cytokines in Breast Cancer: Relationship with Clinicopathological Characteristics of the Tumor. CIMB. 2022;44(10):4676 [Crossref]

6- Ghasemi-Dehkordi P, Doosti A, Jami M. The concurrent effects of azurin and Mammaglobin-A genes in inhibition of breast cancer progression and immune system stimulation in cancerous BALB/c mice. 3 Biotech. 2019;9(7) [Crossref]

7- Bel'skaya L, Sarf E, Kosenok V. Indicators of L-arginine metabolism in saliva: A focus on breast cancer. Journal of Oral Biosciences. 2021;63(1):52 [Crossref]

8- Arianfar E, Shahgordi S, Memarian A. Natural Killer Cell Defects in Breast Cancer: A Key Pathway for Tumor Evasion. International Reviews of Immunology. 2021;40(3):197 [Crossref]

Indexing Info:

Member of: